PSNL
Personalis IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$575.73M
P/E Ratio
—
EPS
$-0.91
Beta
2.21
52W High
$11.50
52W Low
$3.73
50-Day MA
$7.26
200-Day MA
$7.52
Dividend Yield
—
Profit Margin
-116.70%
Forward P/E
—
PEG Ratio
—
About Personalis Inc
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $69.65M |
| Gross Profit (TTM) | $15.78M |
| EBITDA | $-78.01M |
| Operating Margin | -145.70% |
| Return on Equity | -35.00% |
| Return on Assets | -18.20% |
| Revenue/Share (TTM) | $0.78 |
| Book Value | $2.55 |
| Price-to-Book | 2.39 |
| Price-to-Sales (TTM) | 8.27 |
| EV/Revenue | 6.09 |
| EV/EBITDA | -0.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 3.20% |
| Shares Outstanding | $104.68M |
| Float | $68.17M |
| % Insiders | 27.02% |
| % Institutions | 58.02% |
Historical Volatility
HV 10-Day
68.58%
HV 20-Day
67.53%
HV 30-Day
73.12%
HV 60-Day
86.56%
HV Rank
14.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.29 target)
1
Strong Buy5
Buy1
HoldData last updated: 4/29/2026